SUBSCRIBE
SUBSCRIBE

Gleevec Needs Time to Work; Three Months Not Enough To Judge CML Patient Response To Cancer Drug

October 19, 2005 | 
1 min read

Three months is not enough time to gauge the response of people with chronic myeloid leukemia (CML) to treatment with the drug Gleevec (imatinib).